了解传统中医药的LLM方法:机制探索和创新的应用
IEEE journal of biomedical and health informatics
|December 11, 2025
概括
这项研究引入了一种新的大型语言模型 (LLM) 框架,用于中国传统医学 (TCM),增强个性化治疗和临床应用. 人工智能模型有效地捕捉了TCM原则,改善了诊断逻辑,为人工智能驱动的个性化医疗铺平了道路.
科学领域:
- 人工智能的人工智能
- 计算医学是一种计算医学.
- 传统中国医药 传统中国医药
背景情况:
- 大型语言模型 (LLM) 在医学知识表现方面显示出潜力,但在动态的临床工作流程和传统中医 (TCM) 等复杂系统中的个性化治疗方面面临挑战.
- 模拟"同一疾病的不同治疗方法"的核心TCM原则仍然是AI的一个重大挑战.
- 现有的AI框架努力捕捉TCM固有的细微,学校特定的诊断逻辑.
研究的目的:
- 为探索TCM机制和临床应用开发一个高效和新的LLM框架.
- 解决当前LLM在处理TCM所需的复杂性和个性化方面的局限性.
- 创建一个能够理解和应用"同一疾病不同的治疗方法"原则的AI模型.
主要方法:
- 一个两阶段的法学士框架,结合了增量领域特定的预培训,多任务监督微调,以及链式思维 (Chain-of-Thought, CoT) 推理.
- 利用来自19名中医医师的100,538条记录的异构数据库进行模范培训.
- 利用六个下游任务,包括个性化处方生成,以评估临床能力.
主要成果:
- 在LLM框架中,在增量预培训后,BLEU-4得分提高了1,313%,在微调后达到41.26-43.21.
- 正式验证证实了基本配方的关键作用,其删除导致了23.9%的性能下降.
- 校际评估显示了强大的概括能力,在外部数据上获得22.8 BLEU-4. CoT注释提高了20%的性能,仅使用10%的标记数据.
结论:
- 拟议的LLM框架成功地捕捉了TCM的"同一疾病的不同治疗方法"原则,并保留了学校特定的诊断逻辑.
- 该模型展示了高数据效率和强大的泛化,推进了智能TCM继承.
- 这项工作通过增强TCM的临床应用和知识表示,为人工智能驱动的个性化医学铺平了道路.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

